IDO1 and head and neck squamous cell carcinoma: An assessment of drug sensitivity in relation to IDO1 expression in 40 HNSCC cell lines revealed two compounds, MG-132 and Z-LLNIe-CHO, that were positively correlated to IDO1 expression.